Verastem, Inc. Amortization of Debt Issuance Costs
Verastem, Inc. (VSTM) reported Amortization of Debt Issuance Costs of $11.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2026-08-06
- Verastem, Inc. amortization of debt issuance costs for the quarter ending 2025-12-31 was -$18.00K, a 124.66% decline year-over-year.
- Verastem, Inc. amortization of debt issuance costs for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Verastem, Inc. amortization of debt issuance costs for the quarter ending 2025-06-30 was $18.00K, a 73.53% decline year-over-year.
- Verastem, Inc. amortization of debt issuance costs for the quarter ending 2025-03-31 was $11.00K, a 83.33% decline year-over-year.
- Verastem, Inc. amortization of debt issuance costs for fiscal 2025 was $11.00K, a 96.03% decline from fiscal 2024.
- Verastem, Inc. amortization of debt issuance costs for fiscal 2024 was $277.00K, a 20.43% increase from fiscal 2023.
- Verastem, Inc. amortization of debt issuance costs for fiscal 2023 was $230.00K, a 28.49% increase from fiscal 2022.
- Verastem, Inc. amortization of debt issuance costs for fiscal 2022 was $179.00K, a 98.05% decline from fiscal 2021.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month | Amortization of Debt Issuance Costs 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$18.00K derived: sum of 2 quarters · filed 2026-03-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $11.00K 10-K · filed 2026-03-04 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $18.00K derived: sum of 2 quarters · filed 2026-08-06 | $29.00K 10-Q · filed 2025-11-04 | $102.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $29.00K 10-Q · filed 2026-08-06 | $102.00K derived: sum of 3 quarters · filed 2026-08-06 | $173.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $11.00K 10-Q · filed 2026-05-07 | $84.00K derived: sum of 2 quarters · filed 2026-05-07 | $155.00K derived: sum of 3 quarters · filed 2026-05-07 | $223.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $144.00K derived: sum of 2 quarters · filed 2026-03-04 | $212.00K derived: sum of 3 quarters · filed 2026-03-04 | $277.00K 10-K · filed 2026-03-04 | $66.00K 10-Q · filed 2024-05-09 |
| 2024-09-30 | $71.00K 10-Q · filed 2025-11-04 | $139.00K derived: sum of 2 quarters · filed 2025-11-04 | $204.00K 10-Q · filed 2025-11-04 | $260.00K derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-06-30 | $68.00K 10-Q · filed 2025-08-07 | $133.00K 10-Q · filed 2025-08-07 | $189.00K derived: sum of 3 quarters · filed 2026-03-04 | $249.00K derived: sum of 4 quarters · filed 2026-03-04 | |
| 2024-03-31 | $66.00K 10-Q · filed 2025-05-13 | $121.00K derived: sum of 2 quarters · filed 2026-03-04 | $181.00K derived: sum of 3 quarters · filed 2026-03-04 | $238.00K derived: sum of 4 quarters · filed 2026-03-04 | |
| 2023-12-31 | $55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $115.00K derived: sum of 2 quarters · filed 2026-03-04 | $172.00K derived: sum of 3 quarters · filed 2026-03-04 | $230.00K 10-K · filed 2026-03-04 | |
| 2023-09-30 | $60.00K 10-Q · filed 2024-11-06 | $117.00K derived: sum of 2 quarters · filed 2024-11-06 | $175.00K 10-Q · filed 2024-11-06 | $233.00K derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-06-30 | $57.00K 10-Q · filed 2024-08-08 | $115.00K 10-Q · filed 2024-08-08 | $173.00K derived: sum of 3 quarters · filed 2025-03-20 | $230.00K derived: sum of 4 quarters · filed 2025-03-20 | |
| 2023-03-31 | $58.00K 10-Q · filed 2024-05-09 | $116.00K derived: sum of 2 quarters · filed 2025-03-20 | $173.00K derived: sum of 3 quarters · filed 2025-03-20 | $227.00K derived: sum of 4 quarters · filed 2025-03-20 | |
| 2022-12-31 | $58.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $115.00K derived: sum of 2 quarters · filed 2025-03-20 | $169.00K derived: sum of 3 quarters · filed 2025-03-20 | $179.00K 10-K · filed 2025-03-20 | |
| 2022-09-30 | $57.00K 10-Q · filed 2023-11-08 | $111.00K derived: sum of 2 quarters · filed 2023-11-08 | $121.00K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $54.00K 10-Q · filed 2023-08-08 | $64.00K 10-Q · filed 2023-08-08 | |||
| 2022-03-31 | $10.00K 10-Q · filed 2023-05-09 | ||||
| 2021-12-31 | $9.20M 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |